Evidence map›Paper›PMID 32582802›Full record

ArticleReports of biochemistry & molecular biology2020

Analysis of

Atefeh Sohan Forooshan Moghadam, Mitra Ataei, Ghazaleh Arabzadeh, Kowsar Falahati, Fatemeh Roshani, Mohammad Hossein Sanati

Open access · greenAbstract read
In one paragraph

Article in Reports of biochemistry & molecular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Risk Factors from Pregnancy to Adulthood in Multiple Sclerosis Outcome.International journal of molecular sciences · 2022
    Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution.

Atefeh Sohan Forooshan MoghadamDepartment of Biology, Nourdanesh Institute of Higher Education, Meymeh, Isfahan, Iran.
Mitra AtaeiMedical Genetic Department, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
Ghazaleh ArabzadehDepartment of Biology, Nourdanesh Institute of Higher Education, Meymeh, Isfahan, Iran.
Kowsar FalahatiMedical Genetic Department, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
Fatemeh RoshaniDepartment of Biology, Nourdanesh Institute of Higher Education, Meymeh, Isfahan, Iran.
Mohammad Hossein SanatiMedical Genetic Department, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
NourDanesh Institute of Higher Education

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn multiple sclerosis (MS), the immune system acts against myelin lesions of the central nervous system, destroying neuronal fibers resulting in signal transmission disturbances in the nervous system. MicroRNAs play important roles in the post-transcriptional regulation of gene expression and in the regulation of disease activity and its response to treatment. The goal of this study was to determine the role of

methodsRNA was isolated from blood samples of 32 MS patients and 32 healthy individuals, and miR-18a-5p expression was determined by real-time polymerase chain reaction (real-time PCR).

results

conclusionThe reduction of

Indexed as

MicroRNA (miRNA)MiRNA-18a-5pMultiple Sclerosis (MS)

Identifiers

PMID32582802
PMCPMC7275836
OpenAlexW3028500445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.